Long term persistence of herpes simplex virus-specific CD8+ CTL in persons with frequently recurring genital herpes

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 1146-1152

  Posavad, Christine M ^a,b   Huang, Meei Li ^a   Barcy, Serge ^a   Koelle, David M ^a,b   Corey, Lawrence ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENITAL HERPES; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LATENT VIRUS INFECTION; MEMORY CELL; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS REACTIVATION;

EID: 0343517077     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.1146     Document Type: Article

References (34)

1. Fleming, D. T., G. M. McQuillan, R. E. Johnson, A. J. Nahmias, S. O. Aral, F. K. Lee, and M. E. S. Louis. 1997. Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 337:1105.
2. Wald, A., L. Corey, R. Cone, A. Hobson, G. Davis, and J. Zeh. 1997. Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J. Clin. Invest. 99:1092.
3. +, CD8 T cells and is restricted to the DR region of the MHC complex. J, Immunol. 140:3610.
4. + cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. J. Virol. 70:8165.
5. Koelle, D. M., H. Abbo, A. Peck, K. Ziegweid, and L. Corey. 1994. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J. Infect. Dis. 169:956.
6. Koelle, D. M., C. M. Posavad, G. R. Barnum, M. L. Johnson, J. M. Frank, and L. Corey. 1998. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J. Clin. Invest. 101:1500.
7. + cytotoxic T lymphocyte activity. Proc. Natl. Acad. Sci. USA 94:10289.
8. Benedetti, J. K,. J, Zeh, and L. Corey. 1999. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann. Intern. Med. 131:14.
9. Para, M. F., K. M. Zezulak, A. J. Conley, M. Weinberger, K. Snitzer, and P. G. Spear. 1983. Use of monoclonal anybodies against two 75,000-molecular weight glycoproteins specified by herpes simplex virus type 2 in glycoprotein identification and gene mapping. J. Virol. 45:1223.
10. Purves, F. C., D. Spector, and B. Roizman. 1991. The herpes simplex virus type 1 protein kinase encoded by the US3 gene mediates posttranslational modification of the phosphoprotein encoded by the UL34 gene. J. Virol. 65:5757.
11. Preston, V. G., A. J. Davison, H. S. Marsden, M. C. Timbury, J. H. Subak-Sharpe, and N. M. Wilkei. 1978. Recombinants between herpes simplex virus types 1 and 2: analyses of genome structures and expression of immediate early polypeptides. J. Virol. 28:499.
12. + cytotoxic T lymphocytes. J. Clin. Invest. 91:961.
13. Posavad, C. M., and K. L. Rosenthal, 1992. Herpes simplex virus-infected ribroblasts are resistant to and inhibit cytotoxic T-lymphoyte activity. J. Virol. 66: 6264.
14. Chomczynski, P., and N. Sacchi. 1987. Single-step of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
15. + T cell repertoire in normal subjects and monozygotic twins: implications for studies of infectious and autoimmune diseases. Mol. Med. 1:614.
16. Cone, R. C., A. C. Hobson, J. Palmer, M. Remington, and L. Corey. 1991. Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reaction. J. Infect. Dis. 164:757.
17. Cone, R. W., A.C. Hobson, and M. L. Huang. 1992. Coamplified positive control detects inhibition of polymerase chain reactions. J. Cin. Microbiol. 30:3185.
18. Kalams, S. A., R. P. Johnson, A. K. Trocha, M. J. Dynan, H. S. Ngo, R. T. D'Aquila. J. T. Kurnick. and B. D. Walker. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261.
19. Cose, S. C., J. M. Kelly, and F. R. Carbone. 1995. Characterization of a diverse primary herpes simplex virus type 1 gB-specific cytotoxic T-cell response showing a preferential Vβ bias. J. Virol. 69:5849.
20. Wallace, M. E., R. Keating, W. R. Heath, and F. R. Carbone. 1999. The cytotoxic T-cell responses to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J. Virol. 74:7619.
21. + T lymphocytes. Cell 77:525.
22. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411.
23. Fruh, K., K. Ahn, H. Djaballah, P. Semp'e. P. M. v. Enden, R, Tamp'e, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415.
24. Posavad, C. M., J. J. Newton, and K. L. Rosenthal. 1993. Inhibition of human CTL-medialed lysis by fibroblasts infected with herpes simplex virus. J. Immunol. 151:4865.
25. York, I. A., and D. C. Johnson. 1993. Direct contact with herpes simplex virus-infected cells results in inhibition of lymphokine-activated killer cells because of cell-to-cell spread of virus. J. Infect. Dis. 168:1127.
26. Hayward, A. R., G. S. Read, and M. Cosyns. 1993. Herpes simplex virus interferes with monocyte accessory cell function. J. Immnol. 150:190.
27. Lubinski, J., T. Nagashunmugam, and H. M. Friedman. 1998. Viral interference with antibody and complement. Cell Dev. Biol. 9:329.
28. de Campos-Lima. P.-O., V. Levitsky, J. Brooks, S. P. Lee. L. F. Hu, A. B. Rickinson, and M. G. Masucci. 1994. T cell responses and virus evolution: Epstein-Barr virus isolates from highly HLA A11-positive populations carry mutations selectively involving anchor residues of A11-restricted CTL epitopes. J. Exp. Med 179:1297.
29. Lee, S. P., S. Morgan, J. Skinner, W. A. Thomas. S. R. Jones, J. Sutton, R. Khanna, H. C. Whittle, and A. B. Rickinson. 1995. Epstein-Barr virus isolates with the major cytotoxic T cell epitope are prevalent in a highly B35.01-positive African population. Eur. J. Immunol. 25:102.
30. Sasadeusz, J. J., F. Tufaro, S. Safrin, K. Schubert, M. M. Hubinette, P. K. Cheung, and S. L. Sacks. 1997. Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J. Virol. 71:3872.
31. Welsh, R. M., and J. M. McNally. 1999. Immune deficiency, immune silencing, and clonal exhaustion of T cell responses during viral infections. Curr. Opin. Microbiol, 2:382.
32. Lui, S. L., T. Schacker, L. Musey, D. Shriner, M. J. McElrath, L. Corey, and J. I. Mullins. 1997. Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses. J. Virol. 71:4282.
33. + responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy. J. Virol. 73:7108.
34. Altman. J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.